BridgeMD
New treatment option for Kidney Failure, Chronic
Official title Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients
ClinicalTrials.gov ID: NCT06903559
What this study is testing
What is Roxadustat?
Roxadustat is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for kidney failure, chronic.
Also referred to as Evernzo.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Patients with kidney failure who require hemodialysis often suffer from anemia (low red blood cell count), heart and blood vessel problems, and a condition involving poor nutrition, inflammation, and hardening of the arteries (called MIA syndrome). Standard treatments for anemia often involve injections and iron supplements.
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age of patient is more than 18.
- Patients who are willing to sign informed consent.
- Patients with ESKD on chronic hemodialysis for more than 3 months.
You likely can't join if
- Current pregnancy or lactation.
- Patients with pre-existing malignancy.
- Patients with psychosis or on hypnotics.
- Refuse to participate in the study.
- Known history of hematological disorders or other known causes for anemia other than CKD or dialysis.
- Patients with severe cardiovascular disease
The study team makes the final eligibility decision.
Where it's taking place
- Al Mansurah, Dakahliya, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Al Mansurah, Dakahliya, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.